Advanced Solid Tumors Clinical Trials in Shanghai, Shanghai Municipality
36 recruitingShanghai, Shanghai Municipality, China
Showing 1–20 of 36 trials
Recruiting
Phase 1Phase 2
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Ovarian CancerPancreatic CarcinomaAdvanced Solid Tumors+1 more
Evopoint Biosciences Inc.350 enrolled24 locationsNCT06799637
Recruiting
Phase 2
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Advanced Solid TumorsHER2 Mutation
Bayer111 enrolled54 locationsNCT06760819
Recruiting
Phase 1
GenSci143 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Changchun GeneScience Pharmaceutical Co., Ltd.180 enrolled9 locationsNCT07252414
Recruiting
Phase 1Phase 2
A Trial of HRS-6768 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.84 enrolled2 locationsNCT06925581
Recruiting
Phase 1
An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Hangzhou Adcoris Biopharmacy Co., Ltd77 enrolled6 locationsNCT06238401
Recruiting
Phase 1Phase 2
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Advanced Solid Tumors
DualityBio Inc.862 enrolled107 locationsNCT05914116
Recruiting
Phase 1
A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications
Advanced Solid Tumors Harboring RAS Mutations or Amplifications
Jiangsu HengRui Medicine Co., Ltd.120 enrolled1 locationNCT07142980
Recruiting
Phase 1Phase 2
A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors
Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.118 enrolled1 locationNCT06520488
Recruiting
Phase 1Phase 2
A Study of YL202 in Combination With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
Breast CancerAdvanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.414 enrolled20 locationsNCT07169994
Recruiting
Phase 1
Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors
Breast CancerOvarian CancerMetastatic Solid Tumor+2 more
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd110 enrolled2 locationsNCT07156253
Recruiting
Phase 1
A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
Locally Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.220 enrolled10 locationsNCT07050459
Recruiting
Phase 2
Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors
Advanced Solid Tumors
Sheng Zhang84 enrolled1 locationNCT07046650
Recruiting
Phase 1
A Study of HDM2005 in Patients With Advanced Solid Tumor
Advanced Solid Tumors
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.72 enrolled1 locationNCT07004296
Recruiting
Phase 1
Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion
Advanced Solid Tumors
Haisco Pharmaceutical Group Co., Ltd.245 enrolled3 locationsNCT06968572
Recruiting
Early Phase 1
AMT-676 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Multitude Therapeutics Inc.24 enrolled13 locationsNCT06400485
Recruiting
Phase 1
A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors
Advanced Solid TumorsHCC
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.108 enrolled1 locationNCT06764836
Recruiting
Phase 1Phase 2
A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.201 enrolled1 locationNCT06605222
Recruiting
Phase 1Phase 2
GH55 for Advanced Cancers With MAPK Mutations: A Study on Safety and Early Results
Advanced Solid Tumors With MAPK Signal Pathway Mutations
Suzhou Genhouse Bio Co., Ltd.110 enrolled1 locationNCT06310382
Recruiting
Phase 1
Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma
Advanced Solid TumorsRelapsed/Refractory B-cell Lymphoma
InSilico Medicine Hong Kong Limited60 enrolled2 locationsNCT06445517
Recruiting
Phase 1
A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients
Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.150 enrolled1 locationNCT05823285